Dharam P. Pathak

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Hybridization of isatin and benzoxazolinone via a diethyl spacer: a new scaffold for breast cancer drug discovery.

Hybridization of isatin and benzoxazolinone via a diethyl spacer: a new scaffold for breast cancer drug discovery.

Journal: Future medicinal chemistry

Published: June 11, 2026

Elucidation of the Role of TRPV1, VEGF-A, TXA2, Redox Homeostasis, and Inflammatory Cascades in Protection against Cold Injuries by Herbosomal-Loaded PEG-Poloxamer Topical Formulation.

Elucidation of the Role of TRPV1, VEGF-A, TXA2, Redox Homeostasis, and Inflammatory Cascades in Protection against Cold Injuries by Herbosomal-Loaded PEG-Poloxamer Topical Formulation.

Journal: ACS applied bio materials

Published: May 08, 2024

Enhancing oral bioavailability of Ca-DTPA by self double emulsifying drug delivery system (SDEDDS).

Enhancing oral bioavailability of Ca-DTPA by self double emulsifying drug delivery system (SDEDDS).

Journal: Drug development and industrial pharmacy

Published: December 25, 2023

Crystallographic mining driven computer-guided approach to identify the ASK1 inhibitor likely to perturb the catalytic region.

Crystallographic mining driven computer-guided approach to identify the ASK1 inhibitor likely to perturb the catalytic region.

Journal: Journal of biomolecular structure & dynamics

Published: December 09, 2023

A Pharmacological Overview and Recent Patent of Triazine Scaffold in Drug Development: A Review.

A Pharmacological Overview and Recent Patent of Triazine Scaffold in Drug Development: A Review.

Journal: Current organic synthesis

Published: September 14, 2023

Deciphering the Structural Determinants Critical in Attaining the FXR Partial Agonism.

Deciphering the Structural Determinants Critical in Attaining the FXR Partial Agonism.

Journal: The journal of physical chemistry. B

Published: January 07, 2023

In-vitro Evaluation of Triazine Scaffold for Anticancer Drug Development: A Review.

In-vitro Evaluation of Triazine Scaffold for Anticancer Drug Development: A Review.

Journal: Current drug discovery technologies

Published: September 16, 2022

Design and optimization of a novel herbosomal-loaded PEG-poloxamer topical formulation for the treatment of cold injuries: a quality-by-design approach.

Design and optimization of a novel herbosomal-loaded PEG-poloxamer topical formulation for the treatment of cold injuries: a quality-by-design approach.

Journal: Drug delivery and translational research

Published: February 13, 2022

Application of In silico Methods in the Design of Drugs for Neurodegenerative Diseases.

Application of In silico Methods in the Design of Drugs for Neurodegenerative Diseases.

Journal: Current topics in medicinal chemistry

Published: February 01, 2021

Conformational Characterization of the Co-Activator Binding Site Revealed the Mechanism to Achieve the Bioactive State of FXR.

Conformational Characterization of the Co-Activator Binding Site Revealed the Mechanism to Achieve the Bioactive State of FXR.

Journal: Frontiers in molecular biosciences

Published: January 25, 2021

In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.

In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.

Journal: Anti-cancer agents in medicinal chemistry

Published: December 10, 2020

pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent.

pH-dependent Release Matrix Oral Formulation of Prussian Blue to Improve its Efficacy as an Internal Decorporation Agent.

Journal: Current drug delivery

Published: August 28, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026